Parabens, phthalates and the most prevalent formaldehyde will all be removed, with CVS Pharmacy stopping the shipping of store brand products that don’t meet these standards to distribution centers by the end of 2019.
The retailer will have a new assortment of healthier food, health-focused products and expanded beauty selections paired with informational signage throughout the store to help customers discover new offerings.
Through this initiative, Phoenix VA Health Care System nurses will be able to refer veterans to MinuteClinic for the treatment of minor illnesses and injuries through the Veterans Choice Program when clinically appropriate.
The two are joining forces to work with students and administrators at historically black colleges and universities and community colleges across the country to advocate for, adopt and implement 100% smoke- and tobacco-free campus policies.
The simulated store environment allows students to develop work experience and customer service skills while in school and potentially set them up for future internship and employment opportunities with CVS Health.
Thomas Moriarty, who joined the company in 2012, will bring together corporate communications, legal, government affairs and public policy under one operating unit to manage the company's external affairs in Washington, D.C. and state capitals across the country.
Billion Dollar Roundtable member companies each spend $1 billion or more annually for a broad range of goods and services with certified diverse companies whose majority owners primarily are minorities and women.
Retailer is teaming up with the University of Pittsburgh School of Pharmacy and the Pittsburgh Public Schools that will bring its prescription drug abuse prevention program to students in the Pittsburgh Public Schools.
Based on new data about Amgen’s PCSK9 inhibitor cholesterol drug Repatha, CVS Health’s chief medical officer, Dr. Troyen Brennan, told Reuters that the number of patients eligible to use the drug could quadruple. He noted that the data — published in the New England Journal of Medicine and showing Repatha’s ability to reduce heart attack, stroke, heart disease deaths, chest pain hospitalizations and stent and bypass procedures by 15% — would need to be reviewed by heart experts. (Reuters)